Análise químico-farmacêutica e estudo de estabilidade de cefuroxima sódica injetável

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Diversidade morfológica, genética e química de populações naturais de Anemopaegma arvense (Vell.) Stellf

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Avaliação do potencial antimicrobiano de Pouteria spp. e de triterpenos quinonametídeos com enfoque no Helicobacter pylori

Pós-graduação em Ciências Farmacêuticas - FCFAR

Morfoanatomia e histoquímica de órgãos vegetativos e reprodutivos de Brosimum gaudichaudii Trecul (Moraceae)

Pós-graduação em Ciências Biológicas (Botânica) - IBB

A psiquiatrização da existência: dos manicômios à neuroquímica da subjetividade

Pós-graduação em Psicologia - FCLAS

Conversão in vitro e in vivo do pró-fármaco hidroximetilnitrofural, candidato a fármaco antichagásico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Ação antibacteriana de associações de antimicrobianos: nisina, óleos essenciais e compostos majotitários

Pós-graduação em Biologia Geral e Aplicada - IBB

Processos de preparação de complexos fosfínicos de rutênio contendo íon picolinato e/ou diiminas e/ou bifosfinas em sua estrutura, complexos fosfínicos de Rutênio obtidos pelos referidos processos e seus usos.

The invention relates to the synthesis and characterisation of ruthenium(II) phosphine complexes containing picolinate and/or diimine and/or biphosphine ions and having an outstanding pharmacological activity for inhibiting the growth of tuberculosis mycobacteria. These complexes can first be used in the chemical industry, and in the medium and long term, in the pharmaceutical industry. The invention also describes how the activity against tuberculosis bacillus was determined, and how the toxicity of the complexes against macrophage cells within which the tuberculosis bacillus grows was assessed.

Development and validation of a microbiological assay by turbidimetry to determine the potency of cefazolin sodium in the lyophilized powder form

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Development and validation of a rapid turbidimetric assay to determine the potency of ampicillin sodium in powder for injectable solution

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

A indústria farmacêutica da América Latina: um estudo comparativo

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

5CN05 partitioning in an aqueous two-phase system: A new approach to the solubilization of hydrophobic drugs

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Análise da implantação do TPM em uma empresa do ramo farmacêutico

Through observation of the production process industries today, one can encounter the needs of the large uncertainties related improvements and changes in the production environment, a fact that inspired the search for solutions that can respond quickly to these changes. Thus, this paper describes the review of implementation of TPM (total productivity management), which aims to optimize two distinct processes in the Vale do Paraíba´s pharmaceutical industry one of through the pillar of specific improvement. The main objective is to propose an efficient alternative to proposing loss management processes by identifying and eliminating the same in a systematic process. To develop this analysis was necessary to explore concepts of TPM and tools that help in taking data, identification and clarification of the phenomena that cause failures in the process, which were essential to ensure the development of the analysis. The concepts covered are usually presented during an undergraduate degree in Engineering. Data compiled by the analysis are able to serve as a strategic benchmark for decision making by managers, providing alternative response variables and uncertainty of the organizational environment, a fact that facilitates the management of human resources and productive

Estudo da indústria farmacêutica brasileira: a queda das patentes e entrada dos medicamentos genéricos

The objective of this study is to examine the pharmaceutical industry and changes that the fall of patents and entry of generics may cause in the price and consumption of drugs. Thus, there is a brief discussion about the global pharmaceutical industry, from its origins to the present day, showing in particular the case of the United States, today considered the largest industry in this sector. From this, the work seeks to address specifically the Brazilian industry and its regulation. Since the generic law implementation, the participation of this type of medicine has grown significantly in the country. Because they have always been lower than prices of their brand, the cost of treating disease is reduced, which makes generic drugs represent an improvement for consumers in terms of welfare of society

A indústria farmacêutica no Brasil: um estudo do impacto socioeconômico dos medicamentos genéricos

Recently, some countries outside the Triad (Japan, Europe and the United States) have assumed an important role in the pharmaceutical scenario, as large producers, among them stand out Brazil. In the 90s, there were major institutional transformations and the pharmaceutical industry has undergone a reverse specialization process, because liberalization has discouraged production of pharmaceutical chemicals and dependence of imports increased. The law of generics medicines in 1999 emerged as an attempt to increase the population's access to medicines equivalent to ones with brand, with more affordable prices. As a result of this law there was a strengthening of the national capital and a major attraction for foreign companies to brazilian market. This study aims to assess the development trajectory of the country, showing how path-dependence has culminated in greater empowerment of national pharmaceutical industries after the Generics Law in 1999